The aim of the Centre for Genomic and Experimental Medicine (CGEM) is to use genetics and genomics to understand the mechanisms of disease and improve disease prediction, prevention and prognosis.
We are part of the MRC Institute of Genetics & Molecular Medicine at the University of Edinburgh. Our researchers undertake detailed studies of populations, families and individuals to study a wide range of health related conditions. We use state-of-the-art genetic, epigenetic, genomic, statistical, computational, biological and molecular approaches including whole genome sequencing. We apply these in model systems and in clinical studies to systematically investigate disease mechanisms. With this knowledge, we aim to improve disease prediction, prevention, diagnosis and prognosis. Our research is leading to the development of new medicines and better use of existing medicines in clinical trials.
We provide a first-class research and training environment for basic, clinical and genomics research with a strong emphasis and track record in translational research and experimental medicine. Our research has consistently obtained the highest possible ranking in national assessments of research excellence.
At the heart of CGEM strategy is the use of whole genome and epigenome methods and data, which are used to understand how genetic variation between individuals tracks with human traits and disease conditions. We utilise a powerful set of laboratory-based and computational tools to reveal both clear-cut and subtle changes in the human genome, and how this genetic variation affects the encoded information content, to develop improved understanding of a wide range of health related conditions.
As well as improving understanding of these disease states, a key activity across CGEM is translating our research findings into a clinical setting. Although each of these conditions involves a different gene or gene set, there are important methodological and technical commonalities which unifies our research.
By systematically investigating disease mechanisms through genomics, we are making important progress towards improving disease prediction, prevention and prognosis. This includes the development of new medicines and new diagnostic approaches based on genetic knowledge.
Professor Tim Aitman became Director of CGEM in April 2014. He is supported by the Centre Executive, comprised of Section Heads and key academic and business support staff who are responsible for scientific strategy and smooth running of the Centre.
The IGMM Hub provides CGEM with key business support including human resources, finance, communications and administrative support.
|Professor Tim Aitman||Director, Section Head: Genome Medicine|
|Professor David Porteous||Section Head: Medical Genetics|
|Professor Stuart Ralston||Section Head: Rheumatology & Bone Disease|
|Professor Jack Satsangi||Section Head: Gastroenterology|
|Professor Cathy Abbott||Personal Chair of Mammalian Molecular Genetics|
|Professor Donald Salter||Personal Chair of Osteoarticular Pathology|
|Professor Helen Colhoun||AXA Chair in Medical Informatics and Life Course Epidemiology|
|Dr Adam Jackson||Research Manager|
|Angela Ingram||IGMM Operations Manager|
|Stephen Lissaman||IGMM Business Manager|